PUBLISHER: Grand View Research | PRODUCT CODE: 1813950
PUBLISHER: Grand View Research | PRODUCT CODE: 1813950
The global positive airway pressure devices market size was estimated at USD 2.48 billion in 2024 and is projected to reach USD 4.04 billion by 2033, growing at a CAGR of 5.60% from 2025 to 2033. This growth is attributed to the increasing prevalence of sleep apnea, advancements in technology, rising awareness and diagnosis of sleep disorders, and improving healthcare infrastructure.
These factors are fueling the demand for PAP devices globally. Growing health concerns, better diagnostic methods, and technological innovations are shaping the market's future growth prospects. Obstructive sleep apnea is a respiratory disorder wherein the patient faces irregular breathing patterns with reduced oxygen supply to the brain. According to the Saudi Journal of Otorhinolaryngology-Head and Neck Surgery estimates on the global prevalence of obstructive sleep apnea published in 2023, approximately 936 million people are suffering from mild to severe sleep apnea, and among these, 425 million individuals in the age group of 30 to 69 years are suffering from moderate-to-severe sleep apnea. Rapid globalization, changing lifestyles, and unhealthy dietary habits are a few factors contributing to the prevalence of sleep apnea. In addition, growing obesity levels and a lack of physical activity are driving the incidence rate of obstructive sleep apnea.
Rising awareness and diagnosis of sleep disorders are crucial factors propelling market growth. As people become more educated about sleep apnea and its potential risks, they are more likely to seek diagnosis and treatment. Public health campaigns run by organizations such as the American Sleep Apnea Association have helped improve awareness. In addition, improved diagnostic methods such as polysomnography and home sleep tests have made identifying sleep apnea in its early stages easier. The increasing recognition of sleep apnea as a significant health concern drives more individuals to pursue PAP therapy, thus fueling market demand.
The COVID-19 pandemic had a positive impact on the PAP devices market. According to a study published by the National Centre for Biotechnology Information in 2022, obstructive sleep apnea treated with home CPAP was not associated with worse outcomes in hospitalized COVID-19 patients, suggesting that CPAP can be safely continued during the pandemic. Telehealth services improved CPAP adherence, with some reports showing increased usage during lockdowns as patients received better remote support. The pandemic has highlighted the importance of PAP devices in managing sleep disorders and supporting respiratory health in critically ill patients.
Furthermore, according to ResMed's annual report for the fiscal year ending June 30, 2024, the COVID-19 pandemic impacted the company's sales, particularly in its sleep and respiratory care segment. The report indicates an increased demand for ResMed's PAP devices due to the heightened awareness of respiratory health during the pandemic. This surge in demand was driven by the need for practical, non-invasive ventilation options for patients with respiratory issues related to COVID-19. Market players such as ResMed experienced strong revenue growth in its PAP device sales, reflecting its critical role in managing sleep apnea and respiratory complications associated with COVID-19.
Global Positive Airway Pressure Devices Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global positive airway pressure devices market report based on product, application, end use, and region: